Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2025 07:52 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Highlights Data Demonstrating NLRP3 Inflammasome Inhibition Reduces Inflammation, Improves Heart Function, and Restores Glucose Homeostasis and Insulin Sensitivity in Obese Animal Model of Heart Failure (HFpEF) and Type 2 Diabetes

Inflammasome inhibition in obese animal model with heart failure was cardioprotective & improved metabolic parameters.
January 02, 2024 10:00 ET | Source: Transparency Market Research

Potato Starch Market Size to be Worth USD 9.1 billion by 2031, with Notable CAGR of 4.9%| Transparency Market Research, Inc.

Wilmington, Delaware, United States, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Potato starch market was valued at US$ 5.9 billion in 2022. It is expected to expand at a...